Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-26

FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved Par Health USA, LLC's original application for a generic neostigmine methylsulfate product. This marks the availability of a generic version of neo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)